May 09, 2024 / 11:00AM GMT
Operator
Ladies and gentlemen, good day, and welcome to Q4 FY24 and annual results conference call of Alembic Pharmaceuticals Limited. We have with us today Mr. Pranav Amin, Managing Director; Mr. Shaunak Amin, Managing Director; Mr. R K Baheti, Director, Finance and CFO; Mr. Ajay Kumar Desai, Senior VP, Finance; and Mr. Nilesh Wadhwa, Head International Business and Strategy.
(Operator Instructions) Please note that this conference is being recorded.
I now hand the conference over to Mr. R K Baheti. Thank you, and over to you, Mr. Baheti.
Rajkumar Baheti - Alembic Pharmaceuticals Ltd - Chief Financial Officer, Director - Finance, Executive Director
Thanks. Thank you, everyone, for joining our con call. Let me briefly take you through the numbers, financial numbers for quarter ended and year ended 31 March, 2024.
During the quarter, our total revenue grew by 8% to INR1,517 crores, EBITDA is INR263 crores, which is 17% of sales, and it grew by 29% on Y-o-Y basis. Net profit is INR178 crores grew by 17%.
During the financial year, the
Q4 2024 Alembic Pharmaceuticals Ltd Earnings Call Transcript
May 09, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers